SAB Biotherapeutics, Inc.SABSNASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P45
Within normal range
vs 3Y Ago
-0.3x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | -28.55% |
| Q3 2025 | -82.48% |
| Q2 2025 | 8.28% |
| Q1 2025 | 15.90% |
| Q4 2024 | -47.35% |
| Q3 2024 | 19.19% |
| Q2 2024 | 28.68% |
| Q1 2024 | 18.81% |
| Q4 2023 | -160.20% |
| Q3 2023 | -5.48% |
| Q2 2023 | -205.11% |
| Q1 2023 | -840.91% |
| Q4 2022 | 102.65% |
| Q3 2022 | -83.76% |
| Q2 2022 | 53.36% |
| Q1 2022 | -95.52% |
| Q4 2021 | -228.46% |
| Q3 2021 | 159.47% |
| Q2 2021 | -167.55% |
| Q1 2021 | 0.00% |
| Q4 2020 | 0.00% |